Placebo matching BMS-986166
Sponsors
Bristol-Myers Squibb
Conditions
HealthyUlcerative Colitis
Phase 1
A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects
CompletedNCT02790125
Start: 2016-07-28End: 2017-11-07Target: 66Updated: 2017-11-24
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
CompletedNCT03038711
Start: 2017-02-01End: 2017-08-10Updated: 2019-01-30